Affine Formulations Limited, a active public limited company, was established on 04 July 2006 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232MP2006PLC018755. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹6.00 Cr.
Formerly known as Affine Formulations Private Limited. It upholds a compliant status. Employing 26 professional, Its leadership includes Shailendra Biyani (Director), Pradhyumn Nyati (Director), Vijay Kumar Nyati (Director). Past directors included Mahesh Jakhatia, Pavitra Jhanjhari, Manish Nyati. It holds ₹13.39 Cr open charges and ₹8.81 Cr settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 28/10 Talwali Dewas Naka, Indore, Madhya Pradesh, 452010.
U24232MP2006PLC018755
018755
04 July 2006
₹10.00 Cr
₹6.00 Cr
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Affine Formulations Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shailendra Biyani | Director | 15 Apr 2008 | Current |
| Pradhyumn Nyati | Director | 15 Apr 2008 | Current |
| Vijay Kumar Nyati | Director | 04 Jul 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Cfo(Kmp) | - | Past |
| Pramod Abcsdd | Additional Director | 05 Sep 2016 | Past |
| Pramod Abcsdd | Additional Director | 05 Sep 2016 | Past |
| Pramod Abcsdd | Director | 16 Apr 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Affine Formulations Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.5% increase. The company also saw a substantial fall in profitability, with a 28.48% decrease in profit. The company's net worth moved up by a moderate rise of 4.13%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Affine Formulations had a promoter holding of 32.43% and a public holding of 67.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹133,900,000.00
₹88,100,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Sep 2018 | Axis Bank Limited | ₹13.39 Cr | Open |
| 07 Dec 2006 | State Bank Of India | ₹8.81 Cr | Satisfied |
Explore comprehensive loan charge details -
Affine Formulations has a workforce of 26 employees as of Feb 18, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Affine Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Affine Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Affine Formulations Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.
Progress on Affine Formulations Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Gwalior. was documented.
Progress on A charge with Axis Bank Limited of Rs. 13.39 Cr registered on 26 Sep 2018 with Charge ID 100219357 was modified on 08 Feb 2022. was documented.
The activity A charge registered on 07 Dec 2006 via Charge ID 10033474 with State Bank Of India was fully satisfied on 18 Jan 2019. was completed.
A charge with Axis Bank Limited amounted to Rs. 13.39 Cr with Charge ID 100219357 was registered on 26 Sep 2018. was recorded as a recent event.
The activity A charge with State Bank Of India of Rs. 8.81 Cr registered on 07 Dec 2006 with Charge ID 10033474 was modified on 07 Apr 2012. was completed.
The CIN of Affine Formulations Limited is U24232MP2006PLC018755.
Affine Formulations Limited is headquartered at 28/10 Talwali Dewas Naka, Indore, Madhya Pradesh, 452010.
Affine Formulations Limited was incorporated on 04 July 2006.
The current directors of Affine Formulations Limited are
The primary industry of Affine Formulations Limited is Manufacturing.
Affine Formulations Limited is unlisted.
The authorized capital of Affine Formulations Limited is ₹10.00 Cr, and the paid-up capital is ₹6.00 Cr.
The compliance status of Affine Formulations Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX